Clinical Trials Browser

Interventional × Drug-Related Side Effects and Adverse Reactions × apatinib × Clear all

NCT04824352 2024-05-14

AIEO

Phase 2 Suspended

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT04690231 2022-03-15

Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma

Phase NA Completed

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT04351308 2020-05-19

MAPAC

Phase 2 Unknown

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions